Mary Kay Inc. Champions Business Excellence, Ethics and Social Responsibility in Direct Selling Sector and Beauty Industry, Reaps Rewards in Europe
10.7.2019 10:00:00 EEST | Business Wire | Press release
On May 22, the global beauty company announced Chairman and CEO David Holl is among the top ten most reputable chief executives in the world according to Reputation Institute’s 2019 CEO RepTrak® study. Reputation Institute, the world’s leading provider of reputation intelligence, measured the reputation of more than 140 global CEOs and canvassed more than 230,000 individual ratings among the informed public. The study was conducted in January and February of this year.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190710005268/en/
Tara Eustace, President of the Mary Kay Europe Region. (Photo: Mary Kay Inc.)
According to Kylie Wright-Ford, CEO at Reputation Institute, acting responsibly, behaving ethically and caring about social issues are the most important drivers of CEO reputation. In fact, according to Reputation Institute’s findings, CEOs are more likely to be judged on ethics versus profit margins. In this way, the perception of CEOs and the companies they lead are directly correlated.
This meaningful recognition echoes the series of milestones reached by Mary Kay in Europe over the past months. In 2018 and 2019, Mary Kay's Europe Region earned over 90 product and industry awards and counting — a testament to Mary Kay’s mission to enrich women’s lives, offer science-driven products women love and a long-standing commitment to give back to the community.
“In a highly competitive environment, Mary Kay’s business values stand out around the world, and shine in Europe,” said Tara Eustace, President of the Mary Kay Europe Region. “Each of these awards materialize the truth of our commitment; they also provide Independent Beauty Consultants in Europe pride to celebrate with their customers and share product news and updates, while reinforcing confidence in the brand,” added Eustace.
Recent awards include:
Excellence in Direct Selling
Seldia, the European Direct Selling Association, recently recognized Mary Kay Europe as “Best Company of the Year” at its 2018 Astra Awards. In July 2019, Mary Kay Belarus received the “Direct Sales Cosmetic Company Number One Award” from the “Number One” annual national awards. In June 2019, Mary Kay Ukraine was recognized as “Number 1
Direct Selling Cosmetic Brand” in the “Favor of Success” survey. Mary Kay Spain has been the 2014, 2015, 2016 and 2017 “Number 1 Direct Selling Cosmetic Company” according to the Commercial Register data.
Excellence in Women’s Leadership
In April 2019, Mary Kay Russia’s General Manager, Alla Sokolova, received the "Manager of the Year Award” from Russian Business Guide's People of the Year, recognizing her contribution to the development of the Russian economy and entrepreneurship in Russia.
In 2016, 2017, and 2018, Mary Kay Spain's General Manager, Gema Aznar, was featured in YoDona magazine's annual “500 Most Influential Women in Spain” list highlighted in its special edition called “Female Power.”
Excellence in Women’s Entrepreneurship and Empowerment
On May 24, the “Secrets of Big Business with Mary Kay®” program created by Mary Kay Russia was recognized as the “2019 Best Social Project of Russia Award” in the “Social Entrepreneurship” category. In November 2018, Mary Kay Russia had already earned the “Woman Who Matters Award” rewarding women’s entrepreneurship for the “Secrets of Big Business with Mary Kay®” program. “Woman Who Matters” identifies the best initiatives, practices and programs of Russian companies aimed at women’s support.
Mary Kay Russia also received the “2018 Best Social Project of Russia Award” for its “Beauty of Confidence” campaign and Skin Care Labs. The Best Russian Social Project annual contest was held in May, with more than 70 companies submitting their social projects. The program was created to support the Russian government’s plans to strengthen social policies.
Mary Kay Belarus received a “2018 Brand of the Year” Silver Medal in the Social Responsibility category for its socially active position. The award was a result of the implementation of the “Beauty That Counts” program and the company's contribution to the development of women's entrepreneurship in Belarus.
Mary Kay UK received the “Company with Heart Award” at the 2018 UK Pride of Direct Selling Awards for their partnership with the Look Good, Feel Better charity. “The Company with Heart Award” is awarded to the company which has gone the extra mile to make a charitable impact through its philanthropic activities and community engagement work.
Excellence in Digital Training
Mary Kay was recognized in the “2019 Spring Omni Awards” with a coveted gold ranking in the Educational category for its innovative Link & Learn™ sales education system. The e-learning platform hosts a robust learning curriculum designed to amplify educational support for the independent sales force and increase their business success. It also connects Mary Kay Independent Beauty Consultants to a learning community based on content, accessibility and localization. Mary Kay’s Link & Learn™
was also awarded a “2018 Technology Excellence Award” from the Brandon Hall Group last January with a Bronze Medal in the category of Best Advance in Learning Management Technology for External Training.
Excellence in Digital & Printed Tools
In April, Mary Kay Russia’s MirrorMe™ App won the "2019 Best Corporate Media Award” in the "Client Media: Web Media” category. With the Mary Kay® MirrorMe™ mobile application, anyone can create beautiful makeup without any makeup tools.
Mary Kay Russia’s “Applause” magazine for Independent Beauty Consultants won two awards in 2018: the "Media Leader Award” in the category "Best Corporate Magazine" and the “Silver Threads Award” in the category “Best Corporate Edition.”
Excellence as an Employer
Mary Kay Spain and Mary Kay Poland earned the “2018 AON Best Employers Award,” recognizing organizations demonstrating excellence in the workplace.
Product Excellence
With more than 1,500 patents and a team of scientists dedicated to producing innovative products backed by proven results, Mary Kay® products garnered more than 40 awards in 2018 and already 22 in 2019. Among the products distinguished by the Beauty industry and consumers, Mary Kay TimeWise Miracle® 3D set, TimeWise Repair® Lifting Bio-Cellulose Mask, TimeWise® Vitamin C Activating Squares™, and Oil-Free Eye Makeup Remover, were the most rewarded.
About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 55 years ago with three goals: offer rewarding opportunities for women, manufacture irresistible products and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to researching the science behind beauty and to manufacturing cutting-edge skin care, color cosmetics, fragrances and nutritional supplements. Through the Mary Kay Foundation℠, the company has awarded more than $78 million to cancer research and domestic violence shelters. Mary Kay Ash’s original vision continues to shine—one lipstick at a time.
About Reputation Institute
Reputation Institute helps leaders at the world’s largest companies build credibility with the people that matter most to them by delivering data-driven insights about how they are truly perceived. We do this with RepTrak®, an unrivaled technology that provides actionable insights across industry, competitor, and company analysis. Past and present clients have included Whirlpool, Barnes & Noble,The Estée Lauder Companies, JP Morgan Chase & Co., LEGO, P&G, Cisco, and Telefonica, among many others.
About Seldia
Seldia recognizes the outstanding achievements of organizations that demonstrate excellence in empowerment, entrepreneurship and a commitment to producing best-in-the-industry products. Representing 28 national direct selling associations and 20 member-companies throughout Europe, Seldia’s mission is to promote the interest of national direct selling associations and direct selling companies in the European footprint. “Best Company of the Year” recognizes the corporate member that best raises awareness of the direct selling method of distribution, promotes the method’s socio-economic benefits and demonstrates a strong commitment to supporting the mission of Seldia.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190710005268/en/
Contact information
Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 14:42:00 EEST | Press release
2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (Photo: AETOSWire) Net profit from the Group’s businesses increased by 2,301% year-on-year (YoY), driven by the consolidation of Tendam and the mega-merger to form 2PointZero Group, and growth was also supported by new investments in African financial services, entry into the European packaging markets, and steady operational progress across all verticals, bringing the total reported net profit to AED 7.7 billion. Through continued operational integr
Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release
Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
